Blinatumomab (Blincyto) for Ph- ALL Last Updated: April 18, 2016 Result type: Reports Product Line: Pan Canadian Oncology Drug Review Project Number: pCODR 10064 Details
End Tidal CO2 Monitoring Devices: Clinical and Cost-Effectiveness and Guidelines Last Updated: April 23, 2015 Result type: Reports Product Line: Rapid Response Research Type: Devices and Systems Project Number: RA0754-000 Details
Anticoagulant Use Pre- and Post-Hip Fracture and Other Emergency Orthopedic Surgery: A Review of Guidelines Last Updated: March 19, 2015 Result type: Reports Product Line: Rapid Response Research Type: Drug Project Number: RC0641-000 Details
Back and Neck Outcome Measurement Scales in Physiotherapy: Guidelines Last Updated: June 30, 2015 Result type: Reports Product Line: Rapid Response Research Type: Devices and Systems Project Number: RB0882-000 Details
SynCardia Total Artificial Heart for Failing Fontan Circulation: Clinical Effectiveness and Safety Last Updated: October 19, 2015 Result type: Reports Product Line: Rapid Response Research Type: Devices and Systems Project Number: RA0812-000 Details
Home Peritoneal Dialysis: Clinical and Cost-Effectiveness and Guidelines Last Updated: October 28, 2015 Result type: Reports Product Line: Rapid Response Research Type: Devices and Systems Project Number: RA0813-000 Details
ticagrelor (Brilinta) Last Updated: October 10, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: ticagrelor Indications: Prevention of atherothrombotic events with history of myocardial infarction Brand Name: BrilintaManufacturer: AstraZeneca Canada IncProject Number: SR0474-000Project Status: CompleteSubmission Type: New Indication Details
Efinaconazole for Fungal Nail Infections: A Review of the Clinical Effectiveness, Cost-effectiveness, and Guidelines Last Updated: January 15, 2016 Result type: Reports Product Line: Rapid Response Research Type: Drug Project Number: RC0737-000 Details
Secukinumab (Cosentyx) Last Updated: January 21, 2016 Result type: Reports Product Line: Common Drug Review Generic Name: Secukinumab Indications: Arthritis, psoriatic Brand Name: CosentyxManufacturer: Novartis Pharmaceuticals Canada Inc.Project Number: SR0476-000Project Status: CompleteSubmission Type: New Details
Insulin Pumps for Adults with Type 1 Diabetes: A Review of Clinical Effectiveness, Cost-effectiveness and Guidelines Last Updated: December 10, 2015 Result type: Reports Product Line: Rapid Response Research Type: Drug Project Number: RC0731-000 Details
